Application 018031

Type
NDA
Sponsor
WYETH PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001INDERIDE-40/25HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDETABLET;ORAL25MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002INDERIDE-80/25HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDETABLET;ORAL25MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N018031-001INDERIDE-40/25HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE25MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982
N018031-002INDERIDE-80/25HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE25MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 90 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N018031-001INDERIDE-40/2525MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N018031-002INDERIDE-80/2525MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N018031-001INDERIDE-40/2525MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N018031-002INDERIDE-80/2525MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N018031-001INDERIDE-40/2525MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09N018031-002INDERIDE-80/2525MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N018031-001INDERIDE-40/2525MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N018031-002INDERIDE-80/2525MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N018031-001INDERIDE-40/2525MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N018031-002INDERIDE-80/2525MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
13991SUPPL2011-03-23
802SUPPL2011-03-23
33402SUPPL2011-03-21
11128SUPPL2011-03-21
13990SUPPL2010-03-08
11127SUPPL2010-03-05
13989SUPPL2008-01-09
11126SUPPL2008-01-08
801SUPPL2007-03-06
13988SUPPL2007-01-08
800SUPPL2004-06-10